Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space. The combination of ...

An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance ...

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

The trial, presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, marks a major milestone in HIV cure research. It stands out not only for its ...

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI ...

On Wednesday, Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025).

researchers said at the Conference on Retroviruses and Opportunistic Infections. SAN FRANCISCO — Researchers here described how they were able to safely and ethically enroll adolescents in a ...